Clinical trial
EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis
NCT01330628 is registered in ClinicalTrials.gov with Spectranetics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis
- Lead sponsor
- Spectranetics Corporation
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- May 31, 2015
- Enrollment
- 252 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.